Read Gene Spolka Akcyjna Logo

Read Gene Spolka Akcyjna

Develops DNA tests to identify genetic cancer risk for early detection and prevention.

RDG | WAR

Overview

Corporate Details

ISIN(s):
PLRADGN00014 (+1 more)
LEI:
2594003D7O7NDUV8GE29
Country:
Poland
Address:
Dobra Grzepnica-Alabastrowa 8, 72-003 Dobra
Sector:
Professional, scientific and technical activities
Industry:
Research and experimental development on natural sciences and engineering

Description

Read-Gene S.A. is an innovative biotechnology company focused on the commercialization of methods for the detection, prevention, and treatment of malignant tumors. Established in 2005, the company's core operations are centered on three complementary segments: genetic testing, chemoprevention, and clinical trials. It develops and provides advanced DNA tests that identify genetic predispositions to cancer, enabling precise prophylaxis and facilitating earlier treatment. Additionally, the company offers advisory and support services for oncological genetic counseling centers. Read-Gene is distinguished by its strong scientific foundation, with a team of renowned scientists from the International Hereditary Cancer Center, and holds numerous patents for its novel cancer risk assessment technologies.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-03-25 10:54
Regulatory News Service
Decyzja o ochronie patentowej na wynalazek - Content (PL)
Polish 1.0 KB
2024-03-25 10:51
Regulatory News Service
Decyzja o ochronie patentowej na wynalazek - Content (PL)
Polish 1.1 KB
2023-11-22 16:45
Regulatory News Service
Decyzja o ochronie patentowej na wynalazek - Content (PL)
Polish 1.2 KB
2023-11-16 17:31
Legal Proceedings Report
Decyzja o ochronie patentowej na wynalazek - Content (PL)
Polish 1.2 KB
2023-10-26 16:35
Legal Proceedings Report
Decyzja o ochronie patentowej na wynalazek - Content (PL)
Polish 1.2 KB
2023-08-07 12:11
Regulatory News Service
Decyzja o ochronie patentowej na wynalazek - Content (PL)
Polish 1.4 KB
2023-08-07 12:08
Regulatory News Service
Decyzja o ochronie patentowej na wynalazek - Content (PL)
Polish 1.8 KB
2023-08-07 12:04
Registration Form
Decyzja o ochronie patentowej na wynalazek - Content (PL)
Polish 1.2 KB
2023-08-07 12:01
Regulatory News Service
Decyzja o ochronie patentowej na wynalazek - Content (PL)
Polish 1.2 KB
2023-08-02 13:48
Regulatory News Service
Decyzja o ochronie patentowej na wynalazek - Content (PL)
Polish 1.1 KB
2023-08-02 13:45
Legal Proceedings Report
Decyzja o ochronie patentowej na wynalazek - Content (PL)
Polish 1.2 KB
2023-08-01 15:06
Regulatory News Service
Decyzja o ochronie patentowej na wynalazek - Content (PL)
Polish 1.2 KB
2023-08-01 15:04
Regulatory News Service
Decyzja o ochronie patentowej na wynalazek - Content (PL)
Polish 1.2 KB
2023-06-30 17:30
Declaration of Voting Results & Voting Rights Announcements
Wykaz akcjonariuszy posiadających co najmniej 5% głosów na ZWZ READ-GENE S.A. w…
Polish 584 bytes
2023-06-29 13:27
Director's Dealing
powiadomienie_o_transakcjach_-_zmiana.pdf
Polish 11.9 KB

Automate Your Workflow. Get a real-time feed of all Read Gene Spolka Akcyjna filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Read Gene Spolka Akcyjna via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
OncoZenge AB Logo
Developing a non-opioid lozenge for oral pain relief in cancer patients.
Sweden ONCOZ
OPTIBIOTIX HEALTH PLC Logo
Develops microbiome-modulating ingredients and supplements to manage chronic lifestyle diseases.
United Kingdom OPTI
OXFORD BIODYNAMICS PLC Logo
Develops precision blood tests using 3D genomics for cancer diagnosis and therapy guidance.
United Kingdom OBD
Pharnext Logo France ALPHA
PHYSIOMICS PLC Logo
De-risks oncology drug development for pharma/biotech using modeling and simulation.
United Kingdom PYC
PILA PHARMA AB Logo
Clinical-stage biopharma developing a first-in-class oral drug for diabetes and obesity.
Sweden PILA
POOLBEG PHARMA PLC Logo
AI-led biopharma developing drugs for high-need diseases like CRS and metabolic disorders.
United Kingdom POLB
PROTEOME SCIENCES PLC Logo
CRO providing proteomics services & TMT® tags to biopharma for drug discovery & biomarkers.
United Kingdom PRM
PROVEXIS PLC Logo
Develops & licenses Fruitflow®, a patented ingredient for heart health in food & supplements.
United Kingdom PXS
Develops uncopiable atomic fingerprints for anti-counterfeiting, verifiable by smartphone.
United Kingdom N/A

Talk to a Data Expert

Have a question? We'll get back to you promptly.